Literature DB >> 21760564

Echocardiography as a guide for patent ductus arteriosus ibuprofen treatment and efficacy prediction.

Roxane Desandes1, Jean-Marc Jellimann, Mahmoud Rouabah, Fouad Haddad, Emmanuel Desandes, Farid Boubred, Denis S Semama, Rachel Vieux, Jean-Michel Hascoët.   

Abstract

OBJECTIVE: To evaluate echocardiography criteria in predicting the response to ibuprofen treatment.
DESIGN: A prospective cohort study of preterm infants untreated or treated with ibuprofen for patent ductus arteriosus.
SETTING: Three academic neonatal intensive care units. PATIENTS: Two hundred fifty-two preterm infants of 27-31 wks gestation.
INTERVENTIONS: Ibuprofen treatment within the first 5 days of life was indicated when at least two out of four conventional echocardiography criteria were observed: ductal diameter >2 mm, left-right ductal shunt maximum velocity <2 m/sec, mean flow velocity in left pulmonary artery >0.4 m/sec, and end-diastolic flow velocity in left pulmonary artery >0.2 m/sec.
MEASUREMENTS AND MAIN RESULTS: Of the infants analyzed, 135 had a closed ductus at an average age of 1.9 ± 0.9 days, and 43 had an open ductus but <2 predefined criteria. Seventy-four infants (29%) received ibuprofen on day 2.2 ± 1.1. Sixteen infants failed ibuprofen and nine had to undergo surgical ligation. The left-right ductal shunt maximum velocity criterion had the best negative predictive value for treatment response, while the ductal diameter criterion had the best positive predictive value.
CONCLUSIONS: Echocardiography may be a useful tool to help patent ductus arteriosus management. A combined use of ductal diameter and left-right ductal shunt maximum velocity criteria allows a more accurate prediction of the response of infants with patent ductus arteriosus to ibuprofen treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21760564     DOI: 10.1097/PCC.0b013e31822882b5

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  6 in total

1.  Indomethacin vs ibuprofen: comparison of efficacy in the setting of conservative therapeutic approach.

Authors:  Andra Malikiwi; Charlene Roufaeil; Kenneth Tan; Arvind Sehgal
Journal:  Eur J Pediatr       Date:  2014-10-26       Impact factor: 3.183

2.  Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus.

Authors:  N Margreth van der Lugt; Enrico Lopriore; Regina Bökenkamp; Vivianne E H J Smits-Wintjens; Sylke J Steggerda; Frans J Walther
Journal:  Eur J Pediatr       Date:  2012-08-05       Impact factor: 3.183

3.  Expert consensus statement 'Neonatologist-performed Echocardiography (NoPE)'-training and accreditation in UK.

Authors:  Yogen Singh; Samir Gupta; Alan M Groves; Anjum Gandhi; John Thomson; Shakeel Qureshi; John M Simpson
Journal:  Eur J Pediatr       Date:  2015-09-12       Impact factor: 3.183

4.  Validation study of the accuracy of echocardiographic measurements of systemic blood flow volume in newborn infants.

Authors:  Benjamim Ficial; Anna E Finnemore; David J Cox; Kathryn M Broadhouse; Anthony N Price; Giuliana Durighel; Georgia Ekitzidou; Joseph V Hajnal; A David Edwards; Alan M Groves
Journal:  J Am Soc Echocardiogr       Date:  2013-09-26       Impact factor: 5.251

5.  Medical closure of patent ductus arteriosus does not reduce mortality and development of bronchopulmonary dysplasia in preterm infants.

Authors:  Demet Terek; Mehmet Yalaz; Zulal Ulger; Ozge Altun Koroglu; Nilgun Kultursay
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852

6.  Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants.

Authors:  Kai-Hsiang Hsu; Tai-Wei Wu; I-Hsyuan Wu; Mei-Yin Lai; Shih-Yun Hsu; Hsiao-Wen Huang; Tze-Yee Mok; Cheng-Chung Lee; Reyin Lien
Journal:  BMC Pediatr       Date:  2019-06-05       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.